a developer of non-invasive blood tests for the early detection of solid tumor based cancers
Industry Biotechnology
A.I.dvisor tells us that ANIX and GERN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANIX and GERN's prices will move in lockstep.
Ticker / NAME | Correlation To ANIX | 1D Price Change % | ||
---|---|---|---|---|
ANIX | 100% | -2.40% | ||
GERN - ANIX | 28% Poorly correlated | +5.28% | ||
CDTX - ANIX | 27% Poorly correlated | -3.26% | ||
SER - ANIX | 25% Poorly correlated | +5.20% | ||
CLRB - ANIX | 25% Poorly correlated | -3.11% | ||
RPTX - ANIX | 25% Poorly correlated | -1.39% | ||
More |